Marina Udier
Direktor/Vorstandsmitglied bei CELYAD ONCOLOGY SA
Aktive Positionen von Marina Udier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Direktor/Vorstandsmitglied | 11.01.2011 | - |
| Independent Dir/Board Member | 11.01.2011 | - | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Vorstandsvorsitzender | 01.05.2019 | - | |
| Geschäftsführer | 01.01.2016 | 26.02.2020 | |
| Nouscom Srl | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - |
Karriereverlauf von Marina Udier
Ehemalige bekannte Positionen von Marina Udier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Geschäftsführer | 01.01.2016 | - |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
Ausbildung von Marina Udier
| Yale University | Doctorate Degree |
Statistik
International
| Schweiz | 3 |
| Vereinigte Staaten | 3 |
| Belgien | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
| Nouscom Srl | Commercial Services |
- Börse
- Insiders
- Marina Udier
- Erfahrung
